Cosmetics Export OEM: Your EU & US Compliance Guide with QuickOEM

Why EU and US Compliance Are Two Different Games

Exporting cosmetics to Europe and North America looks like one project but is really two. The European Union runs a pre-market notification model under Regulation (EC) 1223/2009, while the United States regulates through MoCRA, the Modernization of Cosmetics Regulation Act, which centers on registration, listing, and post-market oversight. Both require a local accountable party, but the substance, paperwork, and labeling rules differ enough that a formula cleared for one market can fail the other.

Getting compliance right at the design stage is far cheaper than reworking a launched product. The brands that scale across both regions treat regulatory screening as a formulation input, not a final check.

Exporting to the EU: EC 1223/2009

The EU cosmetic framework is built around a single idea: a product must be safe and fully documented before it reaches the market. There is no approval stamp; instead the burden sits with a named entity.

Appoint a Responsible Person

Every cosmetic sold in the EU must have a Responsible Person (RP) established in the EU. The RP carries the legal obligation for compliance and must keep the Product Information File accessible to authorities. Many overseas brands use a contract RP or their distributor; the manufacturing plant cannot fill this role on its own.

Build the Product Information File

The PIF is the backbone of EU compliance. It contains the formulation, manufacturing method, the Cosmetic Product Safety Report (CPSR), proof of claimed effect, and any animal-testing data. EU law requires the PIF to be retained for 10 years after the last batch is placed on the market.

Complete CPNP Notification

Before a product reaches EU shelves it must be notified through the Cosmetic Products Notification Portal (CPNP). The submission includes the formulation, label, RP details, and CPSR summary. CPNP is a notification, not an approval, but without it the product is illegal to sell.

Respect Banned and Restricted Substances

The EU maintains Annex II (banned substances) and Annex III (restricted substances with concentration limits). A formula must be screened against these lists before production. This is where many clean claims quietly break: a plant extract or preservative legal elsewhere may exceed EU limits.

Label With INCI and Flag 26 Fragrance Allergens

EU labels must list ingredients using INCI (International Nomenclature of Cosmetic Ingredients) names. Any of the 26 recognized fragrance allergens present above the threshold must be named explicitly. Nanomaterials require separate communication within the CPNP dossier.

Substantiate Every Claim

EU rules forbid misleading claims. Terms like natural, organic, or hypoallergenic must be backed by evidence. Organic certification such as COSMOS or Ecocert is optional and adds cost, but it is not required by CPNP.

Exporting to the US: FDA MoCRA

The US system is lighter on pre-market control but stricter on tracking and reporting.

Register Facilities and List Products

Under MoCRA each facility that manufactures or processes cosmetics for the US market must register with the FDA and renew every two years. Every product must be listed with its ingredient list and label. Unlike the EU, the FDA does not approve cosmetics before sale.

Report Adverse Events

Serious adverse events must be reported to the FDA within 15 business days, with follow-up records retained. This post-market surveillance obligation catches many brands off guard.

Follow Labeling and GMP Rules

US labeling follows the Fair Packaging and Labeling Act: product identity, net quantity, ingredients (fragrances and colors may be listed collectively rather than fully disclosed), and warnings. MoCRA also directs the FDA to issue Good Manufacturing Practice standards, with draft guidance pointing toward ISO 22716-aligned practices. Claims such as clean, natural, or organic must not mislead.

Documentation You Must Hold

A practical export dossier typically includes the finished formulation with INCI names and concentrations, the CPSR and PIF for the EU, CPNP notification confirmation, FDA facility registration and product listing numbers for the US, COA and MSDS for materials and batches, stability and compatibility data, and correct INCI labeling with claim substantiation.

Choosing a GMP or ISO 22716 Factory

Your factory is your first line of defense. Prioritize sites that hold ISO 22716 cosmetics GMP and can show EU and US export experience. Ask for documented ingredient screening against Annex II and III, the ability to produce INCI-compliant labels, and references for CPNP or MoCRA filings. A capable partner shortens the typical one to two month EU timeline and prevents costly reformulation.

QuickOEM connects brands with 500+ certified factories screened for export readiness, matching the right GMP-capable site to your target market and compliance needs.

Common Pitfalls

• Assuming one formula fits both markets without checking restricted substances.
• Treating CPNP as an approval and shipping before notification is complete.
• Forgetting the EU Responsible Person requirement and having no accountable entity.
• Missing the 26 fragrance allergen labeling threshold.
• Under-counting the 15-day US adverse-event reporting window.
• Skipping GMP-aligned manufacturing and failing later US audits.

Typical Timelines and Costs

As a planning reference, formulation compliance screening takes about one to two weeks, a CPSR safety assessment runs two to four weeks, and CPNP notification is often completed within days of a finished dossier. A realistic end-to-end EU schedule is one to two months. Custom-formulation minimum order quantities at China OEM factories commonly start around 500 to 1,000 units. Reformulation after a failed screen can cost tens of thousands in development and delay a launch by weeks.

Budgets vary, but treating compliance as a planned cost rather than a surprise is the difference between a smooth launch and a recalled batch.